Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
Condition:   Breast Neoplasms Interventions:   Drug: Trilaciclib;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab Sponsor:   wang shusen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials

Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Condition:   Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Interventions:   Drug: Cadonilimab;   Drug: AK117;   Drug: Oxaliplatin;   Drug: Tegafur-gimeracil-oteracil potassium;   Drug: Docetaxel;   Drug: 5-Fluorouracil Sponsor:   Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials